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PharmaceuticalsAbstract Three simple, rapid, selective and sensitive spectrophotometric methods are described for
the determination of rizatriptan benzoate (RTB) in bulk drug and in tablets. The methods are based
on the formation of intense yellow colored ion–pair complexes between RTB and sulphonphthalein
acid dyes, namely, bromophenol blue (BPB), bromocresol purple (BCP), bromothymol blue (BTB)
in chloroform medium. The colored products are measured at 425 nm (RTB–BPB complex, RTB–
BCP complex) and 420 nm (RTB–BTB complex). The reactions were extremely rapid at room tem-
perature and the absorbance values remained constant for 90 min (methods A and B) and over 12 h
(method C). Beer’s law was obeyed in the concentration ranges of 0.8–16.0, 1.0–20.0 and 1.2–
24 lg ml1 with molar absorptivity values of 1.76 · 104, 1.96 · 104 and 1.63 · 104 l mol1 cm1 for
BPB, BCP and BTB methods, respectively. The limits of quantiﬁcation (LOQ) were 0.39, 0.34 and
0.27 lg ml1 for BPB, BCP and BTB methods, respectively. Other method validation parameters,
such as precision, accuracy, robustness, ruggedness and selectivity, were satisfactory. The composi-
tion of the ion–pair was found to be 1:1 by Job’s method. The proposed methods were successfully
applied to the determination of RTB in commercial tablets. No interference was observed from com-
mon tablet adjuvants. Statistical comparison of the results with the reference method showed excel-
lent agreement and indicated no signiﬁcant difference in accuracy and precision.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Rizatriptan benzoate (RTB) is chemically described as
N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethan-
aminemonobenzoate (Fig. 1) and is a selective 5-hydroxytrypta-
mine1B/1D (5-HT1B/1D) receptor agonist. It has a weak afﬁnity
for other 5-HT receptor subtypes and was launched in 1998 for
the acute treatment of migraine in adults (Goadsby, 1998).
Migraine headache is recognized as a chronic disease with
episodic occurrences, typically characterized by recurrent dis-
Figure 1 Structure of rizatriptan benzoate.
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drug function and neurological aura symptoms. The effective-
ness of triptans, which are serotonin 5-HT1B/1D receptor agonist
drugs, in these conditions is due to their ability to block the stim-
ulated secretion of neuropeptides from trigeminal nerves to
break the nociceptive cycle of migraine. These actions also in-
clude constriction ofmeningeal and cerebral bloodvessels (Gory
et al., 2005; Oldman et al., 2002; Williamson et al., 1997).
Rizatriptan (RTB) is not ofﬁcial in any pharmacopoeia. A
survey of literature reveals that RTB has been estimated in hu-
man plasma by liquid chromatography-electrospray tandem
mass spectrometry, LC-MS/MS (Guo et al., 2006; Chen et al.,
2006) and high performance liquid chromatography with ﬂuo-
rescence detection (Qin et al., 2006; Chen et al., 2004) and in hu-
man serum by LC-MS/MS (Vishwanathan et al., 2000).
Development of a rapid, sensitive and selective method for the
determination of RTB is essential for the analysis of drug in
bulk, in drug delivery system and for release dissolution studies.
A few methods are found in the literature for the determination
of RTB in pharmaceuticals and include UV-spectrophotometry
(Amol et al., 2009;Kumari et al.,2010; Vivek et al., 2010;Altinoz
et al., 2002), spectroﬂuorimetry (Altinoz et al., 2002), HPLC
when present alone (Zecevic et al., 2008; Jocic et al., 2007) or
in combination with other anti-migraine drugs (Sagar et al.,
2010). A micro-emulsion electro-kinetic chromatography
(MEEKC) has also been developed for the determination of
RTB and its degradation products (Mahuzier et al., 2001).
To the best of our knowledge, there are four reports on the
use of visible spectrophotometry for the assay of RTB in phar-
maceuticals. The ﬁrst report (Shanmukha Kumar et al., 2010)
is concerned with two methods based on either the formation
of ion–pair complex between RTB and methyl orange which is
extracted into chloroform or redox-complexation reaction in
which iron(III) is reduced by RTB and the resulting iron(II)
complexed with 2,20-bipyridyl. The second report (Dannana
Gowry and Marothu Vamsi, 2007) describes three methods.
First method was based on the oxidative coupling reaction be-
tween RTB with 2,6-dichloroquinone-4-chlorimide (DCQC)
and the color developed was measured at 610 nm. Second
method measures the color produced when sulfonate group
of 1,2-napthoquinone-4-sulfonic acid (NQS) replaces imino
group of indole moiety of RTB at 530 nm. In third method
oxidative coupling product of RTB with brucine in presence
of sodium metaperiodate was measured at 530 nm. Third re-
port (Shanmukha Kumar et al., 2011) consists of three meth-
ods. First method is based on oxidation followed by complex
formation reaction of RTB with 1,10-phenanthroline, ferric
chloride and ortho-phosphoric acid to form an orange red col-
ored chromogen measured at 510 nm. In the second method
the blue colored chromogen formed by reduction of FC-re-agent in alkaline medium by RTB was measured at 610 nm.
Third method was based on the measurement of color devel-
oped by extracted ion association complex between alizarin
red and RTB at 425 nm. Fourth report (Ramzia et al., 2011)
renders one method based on the formation of charge transfer
complex between RTB and 7,7,8,8 tetracyanoquinodimethane
(TCNQ) measured at 744 nm.
However, the reported methods, particularly those based
on chromatography are complex, require expensive experimen-
tal setup and skilled personnel and inaccessible to many labo-
ratories in developing and under developed nations. In
contrast, visible spectrophotometry is considered as the most
convenient analytical technique in most quality control and
clinical laboratories. All the previously reported visible spec-
trophotometric methods are less sensitive and few methods re-
quire a rigid pH control and tedious liquid–liquid extraction
steps, some methods have a relatively narrow linear range
and involve heating step as cited in Table 1.
On the other hand, extraction-free spectrophotometry
based on ion–pair reactions has, in recent years, received con-
siderable attention for the quantitative determination of sev-
eral pharmaceutical compounds (Al-Ghannam, 2006; Abdine
et al., 2002; Manjunatha et al., 2008; Basavaiah et al., 2009
and Shahdousti et al., 2008) owing to its simplicity, speed,
selectivity and sensitivity.
In the present communication, we report the development of
three accurate and precise extraction-free spectrophotometric
methods based on the chloroform soluble ion–pair complexes
between RTB with sulphonphthalein dyes BPB, BCP and
BTB. The absorbance measurements were made at 425 nm
(BPB, BCP) or 420 nmwith BTB without extraction. The meth-
ods were applied to the determination of RTB in tablets. No
interference was observed from the tablet additives. The meth-
ods provide rapid and economic procedures, and more sensitive
compared to the previously reported spectrophotometric meth-
ods (Shanmukha kumar et al., 2010, 2011; DannanaGowry and
Marothu Vamsi, 2007; Ramzia et al., 2011).
2. Experimental
2.1. Instrument
All the absorbance measurements were made using a Systron-
ics model 106 digital spectrophotometer provided with 1 cm
matched quartz cells.
2.2. Materials
Pharmaceutical grade rizatriptan benzoate (RTB) was received
from Jubilant Life Sciences, Mysore, India, as a gift and used
as received. The following formulations were obtained from
commercial sources and subjected to analysis: Rizora-10 and
Rizora-5 from Intas Pharmaceuticals Ltd., Ahmedabad, India.
2.3. Reagents and chemicals
All the reagents and solvents used were of analytical-reagent
grade. Bromophenol blue (BPB), bromocresol purple (BCP)
and bromothymol blue (BTB) (all from Loba Chemie Ltd.,
Mumbai, India) solutions were prepared daily as 0.1% BPB
and BCP in dichloromethane and 0.025% BTB in chloroform.
Table 1 Comparison of the propo sed and the existing visible spectrophotometric methods.
Sl. No. Reagent/s used Methodology kmax (nm) Linear range
(lg ml1) and
e (l mol1 cm1)
Reaction
time (min)
Remarks Ref.
1. (a) Methyl orange Extracted ion–pair complex
was measured
420 10–50
(e= 1.02 · 104)
2 Less sensitive, involves
extraction step
Shanmukha Kumar et al. (2010)
(b) Ferric chloride, 2,20-
bipyridyl
Complex formed between
reduced Fe(II) and 2,20-
bipyridyl measured
490 4–20
(e= 1.0 · 104)
5 Less sensitive, heating
required, multi-step
reaction
2. (a) 2,6-dichloro quinone-4-
chlorimide (DCQC)
Oxidative coupling product
measured
610 5–25 NA NA Less sensitive Dannana Gowry and Marothu Vamsi (2007)
(b) 1,2-napthoquinone-4-
sulfonic acid(NQS)
Color produced by
replacement of imino group
of RTB by sulfonate group
of NQS measured
480 15–75 NA NA Less sensitive
(c) Brucine, sodium
metaperiodate
Oxidative coupling product
measured
530 8–40 NA NA Less sensitive
3. a) Ferric chloride, 1,10-
phenanthroline
Complex formed with 1,10-
phenanthroline, ferric
chloride measured
510 2–10
(e= 3.85 · 104)
10 Heating required, multi-
step reaction, narrow
linear range
Shanmukha Kumar et al. (2011)
(b) Folin–Ciocalteu reagent,
sodium hydroxide
Reduced FC-reagent was
measured
610 2–10
(e= 3.5 · 103)
5 Less sensitive
(c) Alizarin red Extracted ion–pair complex
was measured
425 4–20
(e= 5.4 · 103)
2 Less sensitive, involves
extraction step
4. 7,7,8,8-
tetracyanoquinodimethane
(TCNQ)
Charge transfer complex
measured
744 10–100 NR 15 Less sensitive, heating
required
Ramzia et al. (2011
5. (a) Bromophenol blue (BPB) Extraction free ion–pair
complexes measured
425 0.8–16
(e= 1.76 · 104)
5 Simple, rapid, sensitive,
selective and no heating
step, use of single
reagent and no,
extraction step involved
Proposed methods
(b) Bromocresol purple
(BCP)
425 1–20
(e= 1.96 · 104)
5
(c) Bromothymol blue (BTB) 420 1.2–24
(e= 1.63 · 104)
5
NR: Not reported; NA: Not available.
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Figure 2 Absorption spectra of RTB–BPB (method A), RTB–
BCP (method B) and RTB–BTB (method C) ion–pair complexes.
S974 K.N. Prashanth et al.2.4. Standard stock solution
A stock standard solution of 200 lg ml1 of RTB was prepared
by dissolving accurately weighed 20 mg of pure drug in
chloroform and diluting to the mark with chloroform in a
100 ml calibrated ﬂask. This solution was diluted appropriately
with chloroform to get working concentrations of 20, 25 and
30 lg ml1 for use in methods A, B and C, respectively.
2.5. Recommended methods
2.5.1. BPB method
Varying aliquots of standardRTB solution in chloroform equiv-
alent to 0.8–16.0 lg ml1 (0.2–4.0 ml of 20 lg ml1) were accu-Figure 3 The probable mechanism for the formation of ion–pair
respectively.rately transferred into a series of 5 ml calibrated ﬂasks and the
total volume in each ﬂaskwas brought to 4 ml by adding chloro-
form. After the addition of 1 ml of 0.1%BPB solution in dichlo-
romethane, the content was mixed well and the absorbance of
the ion–pair complex was measured at 425 nm against a reagent
blank similarly prepared without adding RTB solution.
2.5.2. BCP method
Aliquots of 0.2–4.0 ml RTB standard solution in chloroform
(25 lg ml1) equivalent to 1.0–20.0 lg ml1 were measured
accurately and transferred into a series of 5 ml calibrated
ﬂasks. The total volume in each ﬂask was brought to 4 ml by
adding chloroform. To each ﬂask, 1 ml of 0.1% BCP solution
in dichloromethane was added and mixed well. The absor-
bance of the resulting yellow colored chromogen was measured
at 425 nm against reagent blank.
2.5.3. BTB method
Into a series of 5 ml calibration ﬂasks, aliquots (0.2–4.0 ml) of
standard RTB solution (30 lg ml1) equivalent to 1.2–
24.0 lg ml1 RTB were accurately transferred and the total
volume in each ﬂask was brought to 4 ml by adding chloro-
form. To each ﬂask 1 ml of 0.025% BTB solution in chloro-
form was added and mixed well. The absorbance of the
yellow colored ion–pair complex was measured at 420 nm
against the reagent blank.
In all the methods, a calibration graph was prepared by
plotting the increasing absorbance values versus concentration
of RTB. The concentration of RTB was read from the
calibration graph or computed from the respective regression
equation derived using Beer’s law data.
2.5.4. Procedure for tablets
Twenty tablets containing RTB were weighed and pulverized
into a ﬁne powder. An amount of tablet powder equivalentcomplexes with BPB, BCP and BTB in methods A, B and C,
Sensitive and selective spectrophotometric assay S975to 10 mg of RTB was weighed into a 100 ml calibrated ﬂask,
50 ml of chloroform added and the mixture was shaken for
20 min, then the volume was made up to the mark with the
same solvent, mixed well and ﬁltered using Whatman No. 42
ﬁlter paper. The ﬁrst 10 ml portion of the ﬁltrate was discarded
and the subsequent portion was diluted appropriately with
chloroform to get the working concentrations (20, 25 and
30 lg ml1 RTB) and subjected to analysis following the pro-
cedures described above.
2.5.5. Placebo blank analysis
A placebo blank of the composition: talc (35 mg), starch
(25 mg), acacia (20 mg), methyl cellulose (30 mg), sodium cit-
rate (20 mg), magnesium stearate (25 mg) and sodium alginate
(25 mg) was transferred to a 50 ml calibration ﬂask, 30 ml of
chloroform was added and the mixture was shaken for
20 min. Then the volume was made up to the mark with the
same solvent, mixed well and ﬁltered using Whatman No. 42
ﬁlter paper and subjected to analysis using the procedures de-
scribed above.
2.5.6. Synthetic mixture analysis
To the placebo blank of the composition described above,
10 mg of RTB was added and homogenized, transferred to a
100 ml calibrated ﬂask and the solution was prepared as de-
scribed under ‘‘Procedure for tablets’’, and then subjected to
analysis by the procedures described above.
2.5.7. Procedure for stoichiometric relationship
Job’s method of continuous variations of equimolar solutions
was employed: 2.55 · 105 M each of RTB in chloroform and
BPB in dichloromethane (Method A) solutions, 3.19 · 105 M
each of RTB in chloroform and BCP in dichloromethane
(Method B) solutions and 5.1 · 105 M each of RTB and
BTB in chloroform (Method C) solutions were prepared sepa-
rately. A series of solutions was prepared in which the total
volume of RTB and reagent was kept at 5 ml. The drug and
reagent were mixed in various complementary proportions
(0:5, 1:4, 2:3,. . ., 5:0, inclusive) and completed as directed un-
der the recommended procedures. The absorbance of the resul-
tant ion–pair complex was measured at 425 nm in methods A
and B, and 420 nm in method C, respectively.Figure 4 Effect of solvents on the formation of RTB–BPB
complex (8 lg ml1 RTB), RTB–BCP complex (10 lg ml1 RTB)
and RTB–BTB complex (12 lg ml1 RTB).3. Results and discussion
RTB was found to react with the dyes in dichloromethane or
chloroform medium to produce an intense and stable ion–
pair complex. Chemically, the structure of RTB possesses
an aliphatic tertiary amino group and features its basic nat-
ure. This structure suggests the possibility of utilizing an
acidic dye as chromogenic reagent. In dichloromethane or
chloroform RTB does not absorb in the visible region. The
dyes employed have insigniﬁcant absorbance (Fig. 2). The
formation of intense yellow colored product with an absorp-
tion maximum at 425 or 420 nm is due to an opening of lac-
toid ring and subsequent formation of quinoid group
(Ashour et al., 2006). It is supposed that the two tautomers
are present in equilibrium but due to strong acidic nature of
the sulfonic acid group, the quinoid body must predominate.
The more basic aliphatic tertiary amine, due to the two elec-
tron releasing methyl groups, gets protonated prior to otheraromatic amines. Finally, protonated RTB forms ion–pair
with the anionic form of the dye. The possible reaction path-
way is shown in Fig. 3.
3.1. Optimization of variables and method development
3.1.1. Effect of solvent
In order to select a suitable solvent for preparation of the re-
agent solutions used in the study, the reagents were prepared
separately in different solvents such as 1,4-dioxane, chloro-
form, acetonitrile, acetone and dichloromethane, and the reac-
tion of RTB with BPB, BCP or BTB was followed. In methods
A and B as shown in Fig. 4, dichloromethane was best suited
for the preparation of BPB and BCP solutions, respectively.
The chloroform solvent was found to be the ideal solvent for
preparation of BTB for method C (Fig. 4). Similarly, the effect
of the diluting solvent was studied for all methods and the re-
sults showed that none of the solvents except chloroform
formed sensitive and stable colored species in methods A, B
and C. Therefore, chloroform was used for dilution through-
out the investigation.
3.1.2. Effect of dye concentration
The inﬂuence of the concentration of BPB, BCP and BTB on
the intensity of the color developed at the selected wavelength
was studied (Fig. 5). One milliliter each of 0.1% BPB and BCP
or 0.025% BTB was sufﬁcient to produce maximum and repro-
ducible color with minimum blank absorbance.
3.1.3. Effect of reaction time and stability
The optimum reaction time for the development of color at
ambient temperature (30 ± 2 C) was studied and it was found
Figure 5 Effect of reagent concentration on the formation RTB–BPB complex (8 lg ml1 RTB), RTB–BCP complex (10 lg ml1 RTB)
and RTB–BTB complex (12 lg ml1 RTB).
S976 K.N. Prashanth et al.that a 5 min standing time was sufﬁcient for the complete
formation of ion–pair complexes in all the methods. The
formed color was stable for 1 h in methods A and B and it
was stable more than 12 h in method C.
3.1.4. Study of composition of ion–pair complex and its
conditional stability constant
The composition and conditional stability constant of the
RTB–BPB or RTB–BCP or RTB–BTB complex formed were
evaluated by applying Job’s method of continuous variations
(Douglas and Donald, 1971) using equimolar concentrations
of RTB (prepared by following the general procedure) and
the dye. The concentration of dye used in method A was
2.55 · 105 M, method B was 3.19 · 105 M, whereas concen-
tration of RTB and dye is 5.10 · 105 M in method C. The
experiments were performed by mixing equimolar solutions
of drug and reagent by maintaining the total volume at
5.0 ml. The plots of the mole ratio between drug and reagent
versus the absorbance values were prepared (Fig. 6), and the
results revealed that the formation of ion–pair complex be-
tween drug and reagent followed a 1:1 reaction stoichiometry.
The conditional stability constant (Kf) of the ion–associa-
tion complex was calculated from the continuous variation
data using the following equation (Erk, 2003):
Kf ¼ A=Am½1 A=Amnþ2CMðnÞnwhere A and Am are the observed maximum absorbance and
the absorbance value when all the drug present is associated,
respectively. CM is the mole concentration of drug at the max-
imum absorbance and n is the stoichiometry which BPB/BCP/
BTB ion associates with RTB. The logKf values were found to
be 7.75, 6.47 and 7.19 for BPB method, BCP method, and BTB
method, respectively.3.2. Method validation
3.2.1. Analytical parameters
A linear relation was found to exist between absorbance and
the concentration of RTB in the ranges given in Table 2.
The calibration graph in each case is described by the
equation:
Y ¼ aþ bX
where Y= absorbance, a= intercept, b= slope and
X= concentration in lg ml1 obtained by the method of least
squares. Correlation coefﬁcient, intercept and slope for the cal-
ibration data are summarized in Table 2. Sensitivity parame-
ters such as apparent molar absorptivity and Sandell’s
sensitivity values, the limits of detection and quantiﬁcation cal-
culated as per the current ICH guidelines (ICH, 2005) are com-
piled in Table 2 and are indicative of the sensitivity of the
methods. The limits of detection (LOD) and quantiﬁcation
(LOQ) were calculated according to the same guidelines using
the formulae:
LOD ¼ 3:3r=s and LOQ ¼ 10r=s
where r is the standard deviation of ﬁve reagent blank determi-
nations and s is the slope of the calibration curve.
3.2.2. Accuracy and precision
The accuracy and precision of the methods were evaluated by
performing seven replicate analyses on pure drug solution at
three different concentration levels (within the working range).
The relative error (RE %), an indicator of accuracy (Table 3)
was within 1.33 and within day precision, also called the repeat-
ability, expressed as relative standard deviation (RSD %) was
less than 1.25 indicating high accuracy and repeatability of
the methods. The reproducibility of the methods also known
as the day-to-day precision was evaluated by performing repli-
cate analyses on pure drug solution at three levels over a period
Figure 6 Job’s plots obtained for (a) 2.55 · 105 M RTB and BPB ion–pair complex (b) 3.19 · 105 M RTB and BCP ion–pair complex
and (c) 5.1 · 105 M RTB and BTB ion–pair complex.
Table 2 Regression and analytical parameters.
Parameter BPB method BCP method BTB method
kmax (nm) 425 425 420
Beer’s law limits (lg ml1) 0.8–16.0 1.0–20.0 1.2–24.0
Molar absorptivity (l mol1 cm1) 1.76 · 104 1.96 · 104 1.63 · 104
Sandell sensitivitya (lg cm2) 0.0222 0.0198 0.0240
Limit of detection (lg ml1) 0.13 0.11 0.09
Limit of quantiﬁcation (lg ml1) 0.39 0.34 0.27
Regression equation, Yb
Intercept (a) 0.0150 0.0018 0.0005
Slope (B) 0.0502 0.0504 0.0418
Correlation coeﬃcient (r) 0.9996 0.9997 0.9999
Standard deviation of intercept (Sa) 0.00603 0.00641 0.00359
Standard deviation of slope (Sb) 0.00067 0.00057 0.00027
a Limit of determination as the weight in lg per ml of solution, which corresponds to an absorbance of A= 0.001 measured in a cuvette of
cross-sectional area 1 cm2 and l= 1 cm.
b Y= a+ bX, where Y is the absorbance, a is the intercept, b is the slope and X is the concentration in lg ml1.
Sensitive and selective spectrophotometric assay S977
Table 4 Robustness and ruggedness.
Method RTB taken
(lg ml1)
Method robustness Method ruggedness
Parameters altered
Reagent volume
(ml)a
RSD (%)
(n= 3)
Reaction
timeb
RSD (%)
(n= 3)
Inter-analystsaRSD (%)
(n= 4)
Inter-cuvettesaRSD (%)
(n= 4)
BPB
method
4.00 1.21 1.01 1.76 1.38
8.00 0.98 1.22 1.31 1.17
12.00 1.13 0.96 1.03 0.99
BCP
method
5.00 1.23 1.44 0.98 1.43
10.00 1.11 1.24 1.37 1.54
15.00 1.09 1.16 1.59 1.39
BTB
method
6.00 1.19 1.03 0.96 1.53
12.00 0.95 1.26 1.44 1.09
18.00 1.30 1.23 1.06 1.21
a In all methods, the volume of reagent was 0.8, 1.0 and 1.2 ml.
b The reaction time was 4, 5 and 6 min for methods A, B and C.
Table 5 Results of analysis of tablets by the proposed methods.
Tablet brand name Label claim mg/tablet Found (percent of label claim ± SD)a
Reference method Proposed methods
BPB method BCP method BTB method
Rizora-10 10 100.17 ± 0.61 99.76 ± 0.97 100.8 ± 1.03 102.0 ± 1.32
t= 0.80 t= 1.21 t= 3.16
F= 2.53 F= 2.85 F= 3.37
Rizora-5 5 99.89 ± 0.77 101.1 ± 1.12 101.1 ± 1.14 99.31 ± 0.78
t= 1.86 t= 2.02 t= 1.18
F= 2.51 F= 2.19 F= 1.03
Tabulated t-value at the 95% conﬁdence level is 2.78.
Tabulated F-value at the 95% conﬁdence level is 6.39.
a Mean value of ﬁve determinations.
Table 3 Evaluation of intra-day and inter-day precision and accuracy.
Method RTB taken (lg ml1) Intra-day (n= 7) Inter-day (n= 5)
RTB found (lg ml1)a %RSDb %REc RTB found (lg ml1)a %RSDb %REc
BPB method 4.00 4.04 0.40 1.07 4.07 0.69 1.33
8.00 8.06 0.32 0.79 8.11 0.41 0.87
12.00 12.14 0.16 1.18 12.15 0.34 1.25
5.00 5.04 0.35 0.71 4.98 0.58 0.92
BCP method 10.00 9.92 1.25 0.77 9.96 0.92 0.89
15.00 14.92 0.64 0.50 15.03 1.06 0.67
6.00 5.94 0.55 0.98 5.98 0.76 1.13
BTB method 12.00 12.04 0.90 0.31 12.09 1.12 0.51
18.00 17.95 0.56 0.28 18.03 0.83 0.36
a Mean value of ﬁve determinations.
b Relative standard deviation (%).
c Relative error (%).
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Sensitive and selective spectrophotometric assay S979of ﬁve days, preparing all solutions afresh. The day-to-day
RSD values (Table 3) were less than 2% reﬂecting the useful-
ness of the methods in routine analysis.
3.2.3. Robustness and ruggedness
The robustness of the methods was evaluated by making small
incremental changes in the volume of dye (1 ± 0.2 ml) and
contact time (5 ± 1 min), and the effect of the changes were
studied on the absorbance of the ion–pair complex. The
changes had negligible inﬂuence on the results as revealed by
small intermediate precision values expressed as %RSD
(61.44%). Method ruggedness was demonstrated having the
analysis done by four analysts, and also by a single analyst per-
forming analysis using four different cuvettes. Intermediate
precision values (%RSD) in both instances were in the range
0.96–1.76 indicating acceptable ruggedness. These results are
presented in Table 4.
3.2.4. Effect of co-formulated substances
The effect of co-formulated substances was tested by placebo
blank and synthetic mixture analyses. A convenient aliquot
of the placebo blank solution was subjected to analysis accord-
ing to the recommended procedures. There was no interference
by the inactive ingredients as indicated by the near blank
absorbance in all the methods.
The analyses of synthetic mixture solution yielded percent
recoveries which ranged between 98.68–101.31 and with
standard deviation of 0.57–1.21. The results of this study
indicated that the inactive ingredients did not interfere in the
assay.
3.2.5. Application to the analysis of tablets
In order to evaluate the analytical applicability of the pro-
posed methods to the quantiﬁcation of RTB in commercial
tablets, the results obtained by the proposed methods were
compared with those of the reference method (Altinoz et al.,
2002) by applying Student’s t-test for accuracy and F-test for
precision. The reference method consisted of the measurement
of the absorbance of the tablet extract in water at 225 nm. The
results (Table 5) show that the Student’s t- and F-values at
95% conﬁdence level are less than the theoretical values, indi-
cating that there is a good agreement between the results ob-
tained by the proposed methods and the reference method
with respect to accuracy and precision.
3.2.6. Recovery studies
The accuracy and validity of the proposed methods were fur-
ther ascertained by performing recovery studies. Pre-analyzed
tablet powder was spiked with pure RTB at three levels (50%,
100% and 150% of that found in tablet powder) and the total
was determined by the proposed methods. The percent recov-
ery of pure RTB added was in the range 100.3–103.5% with
standard deviation of 0.30–2.12 (Table 6) indicating that the
recovery was good, and that the co- formulated substance
did not interfere in the determination.
4. Conclusions
This paper describes for the ﬁrst time the application of extrac-
tion-free ion–pair complexation reaction for the quantiﬁcation
of RTB in pharmaceutical formulations. Compared with the
S980 K.N. Prashanth et al.existing visible spectrophotometric methods, the proposed
methods are simple, selective, cost-effective, free from auxiliary
reagents and more sensitive as can be seen from the molar
absorptivity values. Moreover, the proposed methods are free
from tedious experimental steps such as heating or extraction
step unlike the previously reported methods (Shanmukha ku-
mar et al., 2010, 2011; Dannana Gowry and Marothu Vamsi,
2007; Ramzia et al., 2011). The most attractive feature of these
methods is its relative freedom from interference by the usual
tablet diluents and excipients in amounts far in excess of their
normal occurrence in pharmaceutical formulations. The statis-
tical parameters and the recovery data reveal good accuracy
and precision of the methods. Hence, recommended methods
are well suited for the assay and evaluation of drug in quality
control laboratories.
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